指南与共识慢性静脉疾病

支持SVS/AVF/AVLS静脉曲张管理指南的系统综述

A systematic review supporting the Society for Vascular Surgery, the American Venous Forum, and the American Vein and Lymphatic Society guidelines on the management of varicose veins.
指南 / 共识 · J Vasc Surg Venous Lymphat Disord · 2021-08-24

本系统综述由SVS、AVF和AVLS指南委员会发起,检索多个数据库回答四个临床问题。纳入73项原始研究(45项RCT)和1项系统综述,采用meta分析。证据支持双功能超声作为诊断大隐静脉功能不全的金标准,并比较了不同治疗方式的闭合率与复发风险。

要点

  • 双功能超声是诊断静脉曲张患者大隐静脉功能不全的金标准(中等确定性证据)。
  • 高位结扎剥脱术5年解剖闭合率与腔内激光消融相似,优于射频消融和超声引导泡沫硬化剂。
  • 热消融较非热消融生活质量评分更低,但复发功能不全风险低于超声引导泡沫硬化剂。

核心结论

  • 证据支持双功能超声用于评估静脉曲张患者,并确认高位结扎剥脱术的长期大隐静脉闭合率与腔内激光消融相似,且优于射频消融和超声引导泡沫硬化剂。

研究设计与样本

  • 系统综述检索多个数据库,针对AVF和SVS指南委员会确定的四个临床问题,由独立评审员配对筛选和评价研究,可行时进行meta分析。
  • 最终纳入73项原始研究(其中45项为随机对照试验)和1项系统综述,来自12,915篇候选文献。

主要发现

  • 中等确定性证据支持双功能超声作为静脉曲张合并慢性静脉功能不全(CEAP C2-C6)患者隐静脉功能不全诊断的金标准。
  • 高位结扎剥脱术在30天和5年的解剖闭合率高于射频消融和超声引导泡沫硬化剂(中等确定性),但与腔内激光消融在5年时无显著差异。
  • 超声引导泡沫硬化剂与高位结扎剥脱术相比复发风险增加;腔内激光消融30天解剖闭合率低于氰基丙烯酸酯闭合,1年和5年闭合率高于超声引导泡沫硬化剂。
  • 热消融与氰基丙烯酸酯闭合或正丁基氰基丙烯酸酯相比,普适生活质量评分更低且不良事件风险增加(低确定性)。
  • 热消融与超声引导泡沫硬化剂相比复发功能不全风险更低,但与氰基丙烯酸酯闭合相比复发功能不全风险更高。

关键数值与推荐

  • 双功能超声作为诊断隐静脉功能不全的金标准(中等确定性证据,CEAP C2-C6患者)。
  • 高位结扎剥脱术在30天和5年解剖闭合率高于射频消融和超声引导泡沫硬化剂(中等确定性证据)。
  • 腔内激光消融30天解剖闭合率低于氰基丙烯酸酯闭合,1年和5年闭合率高于超声引导泡沫硬化剂。
  • 热消融与氰基丙烯酸酯闭合或正丁基氰基丙烯酸酯相比,普适生活质量评分更低且不良事件风险增加(低确定性证据)。

临床怎么用

  • 临床应采用双功能超声评估静脉曲张患者的隐静脉功能不全。
  • 选择治疗方式时需综合考虑闭合率、复发风险、生活质量影响及不良事件风险。
  • 指南推荐应结合患者价值观与偏好、个体解剖因素及手术专长。

局限性

  • 仅单独大隐静脉消融治疗穿通静脉疾病的证据尚无定论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several diagnostic tests and treatment options for patients with lower extremity varicose veins have existed for decades. The purpose of this systematic review was to summarize the latest evidence to support the forthcoming updates of the clinical practice guidelines on the management of varicose veins for the Society for Vascular Surgery (SVS), the American Venous Forum (AVF) and the American Vein and Lymphatic Society. METHODS: We searched multiple databases for studies that addressed four clinical questions identified by the AVF and the SVS guideline committee about evaluating and treating patients with varicose veins. Studies were selected and appraised by pairs of independent reviewers. A meta-analysis was conducted when feasible. RESULTS: We included 73 original studies (45 were randomized controlled trials) and 1 systematic review from 12,915 candidate references. Moderate certainty of evidence supported the usefulness of duplex ultrasound (DUS) examination as the gold standard test for diagnosing saphenous vein incompetence in patients with varicose veins and chronic venous insufficiency (clinical, etiological, anatomic, pathophysiological classification [CEAP] class C2-C6). High ligation and stripping (HL/S) was associated with higher anatomic closure rates at 30 days and 5 years when compared with radiofrequency ablation and ultrasound-guided foam sclerotherapy (UGFS) (moderate certainty), while no significant difference was seen when compared with endovenous laser ablation (EVLA) at 5 years. UGFS was associated with an increased risk of recurrence compared with HL/S. EVLA was associated with lower anatomic closure rates at 30 days than cyanoacrylate closure (CAC) and higher rates at one and 5 years when compared with UGFS. Thermal interventions were associated with lower generic quality of life scores and an increased risk of adverse events when compared with CAC or n-butyl cyanoacrylate (low certainty). Thermal interventions were associated with a lower risk of recurrent incompetence when compared with UGFS and an increased risk of recurrent incompetence than CAC. The evidence for great saphenous vein ablation alone to manage perforator disease was inconclusive. CONCLUSIONS: The current systematic review summarizes the evidence to develop and support forthcoming updated SVS/AVF/American Vein and Lymphatic Society clinical practice guideline recommendations. The evidence supports duplex scanning for evaluating patients with varicose veins and confirms that HL/S resulted in similar long-term saphenous vein closure rates as EVLA and in better rates than radiofrequency ablation and UGFS. Thermal interventions were associated with inferior generic quality of life scores than nonthermal interventions, but had a lower risk of recurrent incompetence than UGFS. The recommendations in the guidelines should consider this information as well as other factors such as patients' values and preferences, anatomic considerations of individual patients, and surgical expertise.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Farah MH, Nayfeh T, Urtecho M, et al. A systematic review supporting the Society for Vascular Surgery, the American Venous Forum, and the American Vein and Lymphatic Society guidelines on the management of varicose veins. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34450355. doi:10.1016/j.jvsv.2021.08.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。